Tedeschi, A. Et Al. 2020. A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. HAEMATOLOGICA , vol.105, no.4 .

Tedeschi, A., Greil, R., DEMİRKAN, F., Robak, T., Moreno, C., Barr, P. M., ... Anz, B.(2020). A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. HAEMATOLOGICA , vol.105, no.4.

Tedeschi, Alessandra Et Al. "A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma," HAEMATOLOGICA , vol.105, no.4, 2020

Tedeschi, Alessandra Et Al. "A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma." HAEMATOLOGICA , vol.105, no.4, 2020

Tedeschi, A. Et Al. (2020) . "A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma." HAEMATOLOGICA , vol.105, no.4.

@article{article, author={Alessandra Tedeschi Et Al. }, title={A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma}, journal={HAEMATOLOGICA}, year=2020}